Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Lilly Stories

2013-11-19 08:27:51

Blockbuster drug has treated an estimated 41 million patients around the globe INDIANAPOLIS, Nov. 18, 2013 /PRNewswire/ -- Cialis is turning 10. As Cialis marks its 10(th) anniversary this week, Lilly is looking back on the last decade in men's health. Conversations that used to be taboo for men are now taking place in bedrooms and exam rooms. Men with conditions like erectile dysfunction (ED) are talking more openly with their partners and their physicians.(1) Part of this evolution was the...

2013-11-18 08:29:07

HILDEN, Germany, and GERMANTOWN, Maryland, November 18, 2013 /PRNewswire/ -- - Collaboration aims to use QIAGEN's companion diagnostic development capabilities to create a companion diagnostic paired with a novel oncology compound from Lilly - New partnership builds on Lilly-QIAGEN framework agreement for development of advanced diagnostic tests to guide treatment with innovative therapies - Third project follows...

2013-11-14 08:32:02

Company's insulin manufacturing commitments over the past year exceed $1 billion INDIANAPOLIS, Nov. 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it will invest more than $700 million to enhance its global insulin manufacturing capacity in Puerto Rico, France and China, as well as in Indianapolis, home to Lilly's global headquarters. Today's news raises Lilly's manufacturing commitment in the past year to more than $1 billion in planned investments in response to...

2013-10-24 16:27:55

INDIANAPOLIS, Oct. 24, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Alfonso "Chito" Zulueta will be promoted to senior vice president and president of the Emerging Markets business effective Jan. 1, 2014. Zulueta will replace Jacques Tapiero who will retire Jan. 31, 2014, after 31 years of service to the company. Zulueta has been president and general manager of Lilly Japan since 2008. In his new role, he will lead the company's efforts in many of the...

2013-10-23 08:29:10

INDIANAPOLIS, Oct. 23, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy. "We are very pleased that the FDA has granted Priority Review to ramucirumab in advanced gastric cancer, as patients with this...

2013-10-23 08:28:57

INDIANAPOLIS, Oct. 23, 2013 /PRNewswire/ -- -- Worldwide revenue increased 6 percent, driven by solid growth for Cymbalta, insulins, Animal Health, Alimta, Cialis and Trajenta. -- Higher revenue and ongoing cost containment drove strong operating income growth. -- Earnings per share totaled $1.11 for the third quarter of 2013. -- 2013 earnings per share guidance narrowed to the range of $4.33 - $4.38 (reported), or $4.10 - $4.15 (non-GAAP). --...

2013-10-22 08:32:43

INDIANAPOLIS, Oct. 22, 2013 /PRNewswire/ -- The Board of Directors of Eli Lilly and Company (NYSE: LLY) has elected Jackson Tai as a new member, effective November 1, 2013. As a member of Lilly's board, Mr. Tai will serve on the Audit and Finance Committees. Tai, 63, serves as a non-executive director of The Bank of China Limited, Singapore Airlines, NYSE Euronext, MasterCard Incorporated, and Royal Philips NV. From 2002 to 2007, he was vice chairman and chief executive officer of...

2013-10-21 16:26:10

INDIANAPOLIS, Oct. 21, 2013 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2013 of $0.49 per share on outstanding common stock. The dividend is payable December 10, 2013 to shareholders of record at the close of business on November 15, 2013. Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide...

2013-10-16 16:25:53

Honoring Outstanding Achievements in Mental Health WASHINGTON, Oct. 16, 2013 /PRNewswire-USNewswire/ -- The National Council for Behavioral Health (National Council) is now accepting nominations for the 2014 Inspiring Hope Awards, supported by Eli Lilly and Company, which recognize exceptional contributions in the fight against mental illness. The Inspiring Hope Awards are built on the legacy of the Lilly Reintegration and Welcome Back Awards and recognize individuals who have shown...

2013-10-15 08:32:32

INDIANAPOLIS, Oct. 15, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the third quarter of 2013 on Wednesday, October 23, 2013. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance. The conference call will be held from 9:00 a.m. to 10:00 a.m. EDT. Investors, media and the general public can access a live webcast of the conference call...